Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 3 Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3 Head and Neck Neoplasms 3 Neoplasms 2 Carcinoma, Squamous Cell 2 Urinary Bladder Neoplasms 1 Melanoma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1

Interventions

pembrolizumab 73 Nivolumab 27 atezolizumab 15 Docetaxel 10 Cyclophosphamide 10 cemiplimab 9 Ipilimumab 9 Paclitaxel 8 Interleukin-2 8 Biopsy 7 fludarabine 6 durvalumab 6 avelumab 6 Taxes 6 Specimen Handling 6 epacadostat 5 Magnetic Resonance Spectroscopy 5 Immune Checkpoint Inhibitors 5 Gemcitabine 5 Drug Therapy 5 Cisplatin 5 Carboplatin 5 spartalizumab 4 Radiotherapy 4 Radiosurgery 4 Pemetrexed 4 Cetuximab 4 utomilumab 3 trametinib 3 poly ICLC 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma × Tiragolumab × Head & Neck × Clear all

NCT05483400 2025-03-30

TIRACAN

University Medical Center Groningen

Phase 2 Recruiting

DermatologicHead & Neck

Head and Neck Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡